Houvast, Ruben D.
Baart, Victor M.
Bhairosingh, Shadhvi S.
Cordfunke, Robert A.
Chua, Jia Xin
Vankemmelbeke, Mireille
Parsons, Tina
Kuppen, Peter J. K.
Durrant, Lindy G.
Vahrmeijer, Alexander L.
Sier, Cornelis F. M. http://orcid.org/0000-0002-4337-2758
Funding for this research was provided by:
Stichting Sacha Swarttouw-Hijmans
H2020 Marie Skłodowska-Curie Actions (861190, 857894, 777682, 872860, 813834)
Article History
Received: 10 April 2020
Revised: 7 July 2020
Accepted: 21 July 2020
First Online: 11 August 2020
Compliance with Ethical Standards
:
: Lindy G. Durrant is CEO and CSO of Scancell Ltd. and has ownership interest in Scancell Ltd. Jia Xin Chua, Mireille Vankemmelbeke and Tina Parsons are employed at Scancell Ltd. All remaining authors declare that they have no conflict of interest.
: The local animal welfare body of the LUMC reviewed and approved all animal studies. Animals received humane care in compliance with the Code of Practice Animal Experiments in Cancer Research. All applicable institutional and/or national guidelines for the care and use of animals were followed.
: The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of Stichting Sacha Swarttouw-Hijmans or the EU H2020 Marie Skłodowska-Curie Actions.